PEOPLE - Changes at MEDEC:
This article was originally published in Clinica
Mark Viminitz and Gerry Stefanatos have been elected to the board of directors of MEDEC, Canada's medical technology industry association. Mr Viminitz is currently general manager of the Cordis division of J&J Medical Products. Mr Stefanatos is general manager of Hospira Healthcare, which is responsible for sales, marketing and distribution of Abbott Canada's hospital products portfolio.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.